1. Hylton，Nola，M. 美国 University of California, San Francisco 2022美国工程院院士 Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after b..
2. 樊代明 中国 空军军医大学 中国工程院院士;2013美国医学院院士 Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from Chin..
3. 樊代明 中国 空军军医大学 中国工程院院士;2013美国医学院院士 Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisati..
4. Rene Bernards 荷兰 The Netherlands Cancer Institute 2020美国科学院院士 Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-ne..
5. Hendrik,Vilstrup 丹麦 University of Aarhus Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy-A Review of the Pas..
6. Sachin,Wani 美国 University of COLORADO American Society for Gastrointestinal Endoscopy guideline on role of endoscopy in the diagnosis of m..
7. Dong, Cheng-Di 中国 国立高雄科技大学 Exploring the Anti-Cancer Effects of Fish Bone Fermented Using Monascus purpureus: Induction ..
8. Guadalupe,Garcia-Tsao 美国 Yale University AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous oblite..
9. Ziv J,Haskal 美国 University of Virginia AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous oblite..
10. Dominique,Thabut 法国 Sorbonne University AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous oblite..
11. Juan G,Abraldes 加拿大 University of Alberta AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous oblite..
12. Carsten,Denkert 德国 Philipps University of Marburg Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual ..
13. Peter A,Fasching 德国 University of Erlangen-Nuremberg Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual ..
14. Michael,Untch 德国 HELIOS Klinikum Berlin-Buch Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual ..
15. Norman,Wolmark 美国 University of Pittsburgh Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual ..
16. Sibylle,Loibl 德国 Goethe University Frankfurt Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual ..
17. Eleftherios P,Mamounas 美国 National Surgery Adjuvant Breast & Bowel Project NSABP Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual ..
18. van't Veer, Laura J. 美国 University of California-San Francisco Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after b..
19. Laura J,Esserman 美国 University of California-San Francisco Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after b..
20. Artemis G,Hatzigeorgiou 希腊 University of Thessaly Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after b..